Dursun et al. investigated the effect of Darbepoetin alpha on atherosclerosis in apo E knockout mice without CKD and showed changes in proteomic profile of treated mice although plaque morphology was not affected [44]. This evidence concerns the gene APOE and chronic kidney disease.